Ginger and Crohn's Disease: IBD, Inflamed Bowel, and Remission

Inflammatory bowel disease (IBD) — disease of Crohn's and ulcerative colitis (UC) — affect more than 1 million Europeans. The ginger, with its action anti-inflammatory ginger specific intestinal, is attracting growing interest as complementary support.

Mechanisms of action in IBD

IBD involves abnormal activation of NF-κB in the intestinal mucosa, leading to overproduction of TNF-α, IL-1β and IL-6. Ginger inhibits this cascade precisely:

• Inhibition of NF-κB in colonocytes (colon cells)
• Reduction of mucosal TNF-α
• Protection of the intestinal epithelial barrier
• Reduction of intestinal permeability (leaky gut)

Preclinical studies on Crohn's and UC

Animal models of colitis (TNBS and DSS) show that ginger extract significantly reduces disease activity scores, leukocyte infiltration and mucosal damage. Human studies are still limited but a pilot study (2019) on 24 patients with mild to moderate UC shows an improvement in endoscopic scores after 8 weeks.

FODMAP and IBD: the choice of sweetener matters

Many IBD patients follow a low FODMAP diet. Erythritol (in INTI Drink) is the best tolerated polyol — 90% absorbed before the colon, it does not ferment or create gas. The cane sugar of comparison INTI vs GIMBER (~34g/100ml) may worsen symptoms in IBD patients sensitive to sucrose.

Ginger as support in remission

Ginger can be considered as additional support in remission to reduce theanti-inflammatory-inflammation-natural-remedy">background inflammation and prevent relapses. It does not replace basic treatments (mesalazine, azathioprine, biological). Consult your ginger gastroenteritis-enterologist before any use.